Alyeska Investment Group’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-137,406
Closed -$480K 716
2025
Q4
$480K Sell
137,406
-43,500
-24% -$294K ﹤0.01% 559
2025
Q3
$1.62M Hold
180,906
﹤0.01% 516
2025
Q2
$1.14M Sell
180,906
-1
-0% -$8 ﹤0.01% 500
2025
Q1
$1.48M Sell
180,907
-57,212
-24% -$564K 0.01% 427
2024
Q4
$2.68M Sell
238,119
-75,835
-24% -$1.12M 0.01% 448
2024
Q3
$6.06M Sell
313,954
-5,025
-2% -$132K 0.03% 332
2024
Q2
$7.18M Buy
+318,979
New +$9.53M 0.04% 304
2024
Q1
Sell
-39,193
Closed -$2.76M 582
2023
Q4
$2.76M Hold
39,193
0.02% 347
2023
Q3
$2.88M Buy
39,193
+12,973
+49% +$1.35M 0.02% 366
2023
Q2
$3.92M Buy
26,220
+6,220
+31% +$860K 0.03% 358
2023
Q1
$1.06M Buy
+20,000
New +$1.2M 0.01% 389
2021
Q4
Sell
-23,327
Closed -$11.5M 706
2021
Q3
$11.5M Buy
23,327
+1,327
+6% +$654K 0.14% 182
2021
Q2
$10.9M Buy
+22,000
New +$10.8M 0.13% 198

Other funds holding PIII

Alyeska Investment Group's PIII Position: Q1 2026 in Review

Alyeska Investment Group sold out of P3 Health Partners (PIII) in Q1 2026, closing a stake of 137,406 shares — an estimated $480K sold.

Alyeska Investment Group first reported a position in PIII in Q2 2021 and held it in 13 quarters. The position peaked at $11.5M in Q3 2021. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • Alyeska Investment Group reported no remaining P3 Health Partners position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 137,406 P3 Health Partners shares in Q1 2026, an estimated $480K.
  • Alyeska Investment Group first reported a position in P3 Health Partners in Q2 2021 and held it in 13 quarters.
  • Alyeska Investment Group's P3 Health Partners position peaked at $11.5M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.